Chargement en cours...
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
The heart is one of the organs most vulnerable to sepsis. This review describes the general characteristics of sepsis-induced cardiomyopathy and the main pathogenesis of myocardial dysfunction in sepsis. Levosimendan is a novel drug for treatment of sepsis-induced myocardial dysfunction. This review...
Enregistré dans:
| Publié dans: | J Int Med Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567749/ https://ncbi.nlm.nih.gov/pubmed/30958071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519837103 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|